Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study of a VA conditioning regimen followed by allogeneic hematopoietic stem cell transplantation in elde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Higher-risk Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: RECRUITING